Skip to main content

Table 1 Characteristics of included studies to estimate the pooled effect of HPV among HIV-infected women in LMICs

From: Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis

First author

Year

Study setting

Study location

Continent

Study design

Sample size

HPV prevalence

HR HPV prevalence

LR HPV prevalence

Age category in years and proportion of HPV

Mean age in years

Median age in years

Age range in years

Veldhuijzen et al. [36]

2011

Health facility

Rwanda

Africa

Cross sectional and cohort

192

139

98

105

< 30 years = 56%,

≥ 30 years = 43.1%

 

27

≥ 18

Sinayobye et al. [37]

2014

District Hospital

Rwanda

Africa

Cross sectional

1228

 

390

 

30–34 = 46.8%,

35–39 = 27.9%,

40–44 = 28.1%,

45–49 = 25.7%,

50–61 = 26.4%

40

 

30–60

Rocha-Brischiliari et al. [38]

2014

Health Facility

Brazil

South America

Standardized questionnaireaand medical record review

178

83

57

26

18–30 = 60.7%,

31–40 = 43.3%,

> 40 = 44.4%

–

–

18–66

Bollen et al. [43]

2006

Bangkok hospitals

Thailand

Asia

Medical records review

256

91

60

 

< 20 = 34.5%,

20–25 = 41.2%,

25–30 = 32.1%,

> 30 = 25.7%

 

25

17–39

McDonald et al. [44]

2014

clinic site

South Africa

Africa

Cohort

1371

718

  

17–29 = 56.5%,

30–39 = 53.6%,

40–65 = 33.3%

 

34

17–65

Firnhaber et al. [45]

2010

teaching hospital

South Africa

Africa

Cross-sectional

1010

191

    

34

18–65

Firnhaber et al. [46]

2009

teaching hospital

South Africa

Africa

Cohort

148

141

123

  

36

 

18–65

Nweke et al. [41]

2013

Gynecologic outpatient clinic

Nigeria

Africa

Cross-sectional

98

45

37

  

36.8

 

≥ 18

Denny et al. [47]

2008

Primary health care clinic and colposcopy clinic

South Africa

Africa

Longitudinal cohort study

400

 

269

  

29.1

 

18–54

Akarolo-Anthony et al. [42]

2013

Hospital

Nigeria

Africa

Cross-sectional

149

 

53

  

36.6

 

≥ 18

Sahasrabuddhe et al. [48]

2007

University Teaching Hospita

Zambia

Africa

Cross sectional

145

141

131

87

 

36.2

  

Rousseau et al. [49]

2006

public health facility

Burkina Faso

Africa

Cross-sectional

126

110

89

21

  

28

16–54

Helen [52]

2017

HIV treatment centers

Burkina Faso and South Africa

Africa

Prospective cohort

1238

1151

842

109

  

35

≥ 15

Hawes et al. [23]

2003

Infectious-disease clinic

Senegal

Africa

Colposcopically directed cervical biopsy specimens

426

289

222

  

33.6

 

> 15

Mattos et al. [39]

2011

(STI/AIDS) clinic

Vitoria, Brazil

South America

Descriptive study

112

33

18

15

  

29

14–51

Nicol et al. [40]

2013

Institute of clinical research, Hospital and HIV VCT

Brazil

South America

Cross sectional

532

369

   

37.7

  

Sagna et al. [35]

2010

Medical center

Burkina Faso

Africa

 

156

91

   

33.65

 

19–45

Munoz et al. [51]

2013

Health facility

Colombia

South America

Cross sectional

194

136

  

20–34 years = 65 (73.9%),

35–49 years = 42 (60%),

≥ 50 years = 29(80.6%)

38

  

Camargo et al. [50]

2014

Hospital based

Colombia

South America

Cross-sectional

216

149

   

37.5

 

20–73